Literature DB >> 25987198

The effects of aggression on symptom severity and treatment response in a trial of cognitive behavioral therapy for panic disorder.

Clair Cassiello-Robbins1, Laren R Conklin2, Ujunwa Anakwenze2, Jack M Gorman3, Scott W Woods4, M Katherine Shear5, David H Barlow2.   

Abstract

BACKGROUND: Previous research suggests that patients with panic disorder exhibit higher levels of aggression than patients with other anxiety disorders. This aggression is associated with more severe symptomatology and interpersonal problems. However, few studies have examined whether higher levels of aggression are associated with a worse treatment response in this population.
METHODS: The present study sought to examine the association of aggression with panic disorder symptom severity in a sample of 379 patients who participated in a trial examining long-term strategies for the treatment of panic disorder.
RESULTS: We found that aggression was significantly associated with higher baseline levels of panic disorder symptoms, anxiety, depression, and functional impairment. Further, we found that patients higher in aggression did not achieve the same level of improvement in general anxiety symptoms during treatment compared to patients lower in aggression, even when controlling for baseline anxiety symptom severity.
CONCLUSION: These results suggest that more research is needed concerning patients with anxiety disorders with higher aggression, as they may be a group in need of additional treatment considerations.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 25987198      PMCID: PMC4459913          DOI: 10.1016/j.comppsych.2015.04.012

Source DB:  PubMed          Journal:  Compr Psychiatry        ISSN: 0010-440X            Impact factor:   3.735


  32 in total

1.  SECOND-STAGE TREATMENTS FOR RELATIVE NONRESPONDERS TO COGNITIVE BEHAVIORAL THERAPY (CBT) FOR PANIC DISORDER WITH OR WITHOUT AGORAPHOBIA-CONTINUED CBT VERSUS SSRI: A RANDOMIZED CONTROLLED TRIAL.

Authors:  Laura A Payne; Kamila S White; Matthew W Gallagher; Scott W Woods; M Katherine Shear; Jack M Gorman; Todd J Farchione; David H Barlow
Journal:  Depress Anxiety       Date:  2015-12-10       Impact factor: 6.505

2.  Overt irritability/anger in unipolar major depressive episodes: past and current characteristics and implications for long-term course.

Authors:  Lewis L Judd; Pamela J Schettler; William Coryell; Hagop S Akiskal; Jess G Fiedorowicz
Journal:  JAMA Psychiatry       Date:  2013-11       Impact factor: 21.596

3.  Anger problems across the anxiety disorders: findings from a population-based study.

Authors:  Kirsten A Hawkins; Jesse R Cougle
Journal:  Depress Anxiety       Date:  2010-12-13       Impact factor: 6.505

4.  Reliability and validity of a structured interview guide for the Hamilton Anxiety Rating Scale (SIGH-A).

Authors:  M K Shear; J Vander Bilt; P Rucci; J Endicott; B Lydiard; M W Otto; M H Pollack; L Chandler; J Williams; A Ali; D M Frank
Journal:  Depress Anxiety       Date:  2001       Impact factor: 6.505

5.  The Work and Social Adjustment Scale: a simple measure of impairment in functioning.

Authors:  James C Mundt; Isaac M Marks; M Katherine Shear; John H Greist
Journal:  Br J Psychiatry       Date:  2002-05       Impact factor: 9.319

6.  Factors related to dropout from treatment in two outpatient treatments for borderline personality disorder.

Authors:  Susan Wnuk; Shelley McMain; Paul S Links; Liat Habinski; Joshua Murray; Tim Guimond
Journal:  J Pers Disord       Date:  2013-05-29

7.  Alexithymia and emotional intelligence in patients with panic disorder, generalized anxiety disorder and major depressive disorder.

Authors:  Elif Onur; Tunc Alkın; Michael J Sheridan; Thomas N Wise
Journal:  Psychiatr Q       Date:  2013-09

8.  Patient characteristics and variability in adherence and competence in cognitive-behavioral therapy for panic disorder.

Authors:  James F Boswell; Matthew W Gallagher; Shannon E Sauer-Zavala; Jacqueline Bullis; Jack M Gorman; M Katherine Shear; Scott Woods; David H Barlow
Journal:  J Consult Clin Psychol       Date:  2013-01-21

9.  Does maintenance CBT contribute to long-term treatment response of panic disorder with or without agoraphobia? A randomized controlled clinical trial.

Authors:  Kamila S White; Laura A Payne; Jack M Gorman; M Katherine Shear; Scott W Woods; John R Saksa; David H Barlow
Journal:  J Consult Clin Psychol       Date:  2012-11-05

10.  Prevalence and correlates of suicidal behavior among soldiers: results from the Army Study to Assess Risk and Resilience in Servicemembers (Army STARRS).

Authors:  Matthew K Nock; Murray B Stein; Steven G Heeringa; Robert J Ursano; Lisa J Colpe; Carol S Fullerton; Irving Hwang; James A Naifeh; Nancy A Sampson; Michael Schoenbaum; Alan M Zaslavsky; Ronald C Kessler
Journal:  JAMA Psychiatry       Date:  2014-05       Impact factor: 21.596

View more
  4 in total

1.  How does hostile resistance interfere with the benefits of cognitive-behavioral therapy for panic disorder? The role of therapist adherence and working alliance.

Authors:  Rachel A Schwartz; Kevin S McCarthy; Nili Solomonov; Dianne L Chambless; Barbara Milrod; Jacques P Barber
Journal:  Psychother Res       Date:  2022-02-24

2.  A Preliminary Examination of the Effects of Transdiagnostic Versus Single Diagnosis Protocols on Anger During the Treatment of Anxiety Disorders.

Authors:  Clair Cassiello-Robbins; Shannon Sauer-Zavala; Julianne G Wilner; Kate H Bentley; Laren R Conklin; Todd J Farchione; David H Barlow
Journal:  J Nerv Ment Dis       Date:  2018-07       Impact factor: 2.254

3.  Patient, therapist, and relational antecedents of hostile resistance in cognitive-behavioral therapy for panic disorder: A qualitative investigation.

Authors:  Rachel A Schwartz; Dianne L Chambless; Barbara Milrod; Jacques P Barber
Journal:  Psychotherapy (Chic)       Date:  2021-02-04

4.  Uncovering the hierarchical structure of self-reported hostility.

Authors:  Martijn W van Teffelen; Jill Lobbestael; Marisol J Voncken; Frenk Peeters
Journal:  PLoS One       Date:  2020-09-29       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.